glp 1 charles barkley on Losing Weight with GLP-1s Charles Barkley on Mounjaro &
Description
Tried Sprout Health
Discover what clinical evidence reveals about GLP-1 receptor agonists and thyroid cancer risk, who should exercise caution, and essential safety guidance for UK patients.
According to PharmaTrac data., Mounjaro launched in March last year, added Rs.105 crore in December, taking its total sales to Rs.600 crore in sales, reflecting rapid uptake despite hardly any insurance coverage and outofpocket affordability constraints.
Prospective, standardised, and adequately powered studies with pre-specified respiratory endpoints are required to move from signal detection to causal inference.
Read the brief:
